跳至主要内容
临床试验/NCT01565213
NCT01565213已完成3 期

Transdiagnostic Group Treatments for Patients With Common Mental Disorders in Primary Health Care: A Randomized Controlled Trial

Karolinska Institutet2 个研究点 分布在 1 个国家目标入组 245 人开始时间: 2006年1月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
245
试验地点
2
主要终点
Change in Quality of life as measured by the SF-36 (Mental Component Score)

研究概览

简要总结

The purpose of this study is to compare the effects of CBT and MMI on the quality of life and relief of psychological symptoms of patients with common mental disorders or problems attending primary health care centre.

详细描述

Design:

Clinical randomised non blinded controlled trial.

Setting:

The study was performed in an outpatient primary health care centre serving 36 000 inhabitants.

Participants:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with common mental disorders or problems

排除标准

  • patients were excluded if:
  • they met diagnostic criteria for bipolar or psychotic disorder or severe personality disorder,
  • were judged to be at risk of committing suicidal acts, and
  • if they had undergone MMI earlier. The investigators paid no consideration to whether patients were treated with SSRI medication.

结局指标

主要结局

Change in Quality of life as measured by the SF-36 (Mental Component Score)

时间窗: Change from baseline in SF-36 at 52 weeks

次要结局

  • Change in Psychopathology as measured by the Comprehensive Psychopathological Rating Scale Self-asssessmen (CPRS-S-A)(Change from baseline in CPRS-S-A at weeks 52)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kersti Ejeby

MD Head GP

Karolinska Institutet

研究点 (2)

Loading locations...

相似试验

Transdiagnostic Group Treatments for Patients With... | 临床试验